2m 2m 2m 2m 2m 2m 2m
TSCAN THERAPEUT (TCRX)
NASDAQ
$0.96-$0.02 (-1.65%)
Price as of Jun 03, 2026 6:43 PM EDT- $66.0MMarket Cap
- -44.00%1-Year Change
- BiotechnologyIndustry
TSCAN THERAPEUT (TCRX)
$0.96-$0.02 (-1.65%)
TCRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.97 | ||
Change | -$0.03 (-2.97%) | ||
Open | $1.00 | ||
High | $1.01 | ||
Low | $0.94 | ||
Previous Close | $0.98 | ||
Volume | 445,688 | ||
30-Day Average Volume | 656,429 | ||
1-Week Change | -8.41% | ||
1-Month Change | -19.67% | ||
1-Year Change | -44.00% | ||
3-Year Change | -65.12% | ||
5-Year Change | -96.09% | ||
Fundamentals | |||
Shares Outstanding | 61.1M | ||
Total Assets | $202.0M | ||
Market Cap | $66.0M | ||
Enterprise Value | -$29.4M | ||
Period: QTR TTM FY | |||
Revenue | $982,000.00 | ||
Net Income | -$28.7M | ||
Free Cash Flow | -$24.3M | ||
EBIT | -$28.0M | ||
EBITDA | -$27.3M | ||
Net Working Capital | $112.8M | ||
EPS | -$0.22 | ||
Enterprise Value/EBITDA | 1 | ||
Enterprise Value/Revenue | -30 | ||
P/B | 1 | ||
P/E | -5 | ||
PEG | 0 | ||
Price/Free Cash Flow | -3 | ||
Price/Operating Cash Flow | -3 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue